Drug Type Small molecule drug |
Synonyms ComboLT |
Target |
Action inhibitors, modulators |
Mechanism ACE inhibitors(Angiotensin-converting enzyme inhibitors), NKCC2 inhibitors(Sodium-(potassium)-chloride cotransporter 2 inhibitors), Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Czechia (28 Sep 2017), |
Regulation- |
Molecular FormulaC16H20N4O3S |
InChIKeyNGBFQHCMQULJNZ-UHFFFAOYSA-N |
CAS Registry56211-40-6 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Essential Hypertension | Czechia | 28 Sep 2017 | |
| Essential Hypertension | Lithuania | 28 Sep 2017 | |
| Essential Hypertension | Slovakia | 28 Sep 2017 | |
| Essential Hypertension | Poland | 28 Sep 2017 | |
| Heart Failure | Poland | 28 Sep 2017 | |
| Heart Failure | Czechia | 28 Sep 2017 | |
| Heart Failure | Slovakia | 28 Sep 2017 | |
| Heart Failure | Lithuania | 28 Sep 2017 |





